Bristol Myers Net Income Applicable To Common Shares History
| BMY Stock | USD 58.12 0.01 0.02% |
Net Income Applicable To Common Shares | First Reported 2000-03-31 | Previous Quarter 2.2 B | Current Value 1.1 B | Quarterly Volatility 1.3 B |
Macro event markers
Latest Bristol Myers' Net Income Applicable To Common Shares Growth Pattern
Bristol Myers' Net Income Applicable To Common Shares moved 4.76% in the latest year, within a very volatile multi-year range. The prior-year reading of 7.1 B moved to 7.4 B, a 4.76% change. Where Bristol Myers' current Net Income Applicable To Common Shares sits relative to the trend line signals whether recent performance is above or below the long-run pace.
| Net Income Applicable To Common Shares | 10 Years Trend |
|
No forward-looking guarantees are expressed or implied by this data.
Net Income Applicable To Common Shares |
| Timeline |
Net Income Applicable To Common Shares Trend Statistics
| Arithmetic Mean | 2,797,864,706 | |
| Geometric Mean | 4,109,617,214 | |
| Coefficient Of Variation | 176.58 | |
| Mean Deviation | 3,346,947,405 | |
| Median | 3,709,000,000 | |
| Standard Deviation | 4,940,569,099 | |
| Sample Variance | 24409223T | |
| Range | 17B | |
| R-Value | 0.05 | |
| Mean Square Error | 25965610.4T | |
| R-Squared | 0.0027 | |
| Significance | 0.84 | |
| Slope | 51,052,941 | |
| Total Sum of Squares | 390547568.4T |
Bristol Myers Net Income Applicable To Common Shares History
| 2026 | 7.4 B | ||
| 2025 | 7.1 B | ||
| 2024 | -8.9 B | ||
| 2023 | 8 B | ||
| 2022 | 6.3 B | ||
| 2021 | 7 B | ||
| 2020 | -9 B | ||
| 2019 | 3.4 B | ||
| 2018 | 4.9 B | ||
| 2017 | 1 B | ||
| 2016 | 4.5 B | ||
| 2015 | 1.6 B | ||
| 2014 | 2 B | ||
| 2013 | 2.6 B | ||
| 2012 | 2 B |
Related Accounts
| Last Reported | End Of Year Estimate | ||
| Net Income Applicable To Common Shares | 7.1 B | 7.4 B |
Methodology, Assumptions & Data Sources
A multi-year look at Bristol Myers's Net Income Applicable To Common Shares is shown below. Some metrics drift back toward their average over time.
Data shown for Bristol Myers Squibb is aggregated from periodic company reporting and market reference feeds and normalized across reporting formats. Professional analyst research is incorporated when coverage is available. Source publication cadence can introduce delays. This section presents reference data and historical patterns only and does not constitute an investment recommendation or advice.